Reuters logo
BRIEF-Cadila Healthcare says Zydus gets final approval from U.S. FDA for candesartan cilexetil tablets
August 24, 2017 / 6:24 AM / 3 months ago

BRIEF-Cadila Healthcare says Zydus gets final approval from U.S. FDA for candesartan cilexetil tablets

Aug 24 (Reuters) - Cadila Healthcare Ltd:

* Says Zydus receives final approval from USFDA for Candesartan Cilexetil tablets

* Says drug is used for treatment of hypertension in adults

* Says drug will be manufactured at co's formulations manufacturing facility at Moraiya Ahmedabad Source text: (bit.ly/2w6shuq) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below